Results 181 to 190 of about 105,659 (312)

Patient experience and procedural safety in prostate biopsy: interpreting patient-reported outcome measures in the era of transperineal biopsy. [PDF]

Transl Androl Urol
Sordelli F, Uleri A, Ploussard G, Baboudjian M.   +3 more
europepmc   +1 more source

Safety of Single-Dose Oral Cefaclor Prophylaxis in Transperineal Prostate Biopsy. [PDF]

Res Rep Urol
Iwagami S, Miyai H, Nishihata M.
europepmc   +1 more source

Peptide‐based responsive molecular fluorescent probes for precision oncology

Responsive Materials, EarlyView.
Peptide‐based responsive fluorescent probes have emerged as adaptive functional materials for precision tumor theranostics, combining tumor‐selective recognition, programmable stimulus responsiveness, and modular tunability. They enable high‐contrast imaging, intraoperative guidance, real‐time monitoring, and multimodal applications, while next ...
Xing Wang, Wen Liu, Jiahao Zhang, Wanqi Wang, Zhicheng Jin, Yuqi Tang, Quan Li   +6 more
wiley   +1 more source

Meta learning optimized TabNet for small sample repeat prostate biopsy prediction. [PDF]

Discov Oncol
Lou J, Xu J, Mao D, Zhao Y, Ye F, Wu M.
europepmc   +1 more source

Biopsy of Prostate [PDF]

, 2020
openaire   +1 more source

Activatable smart contrast agents for photoacoustic imaging

Smart Molecules, EarlyView.
This review highlights recent advances in smart activatable photoacoustic imaging (PAI) contrast agents, which dynamically modulate their optical properties in response to external stimuli or microenvironmental cues. It discusses their molecular design, activation mechanisms, biomedical applications, and future prospects for clinically tailored use ...
Donghyeon Oh, Jihye Lee, Suyoung Park, Juyoung Yoon, Won Jong Kim, Chulhong Kim   +5 more
wiley   +1 more source

Technical development in high‐intensity focused ultrasound for localized prostate cancer: Intraoperative compression of the prostate

UroPrecision, EarlyView.
Abstract High‐intensity focused ultrasound (HIFU) has emerged as a widely adopted, minimally invasive treatment for localized prostate cancer (PC). Although originally applied for whole‐gland treatment, recent advancements in imaging and technology have facilitated the adoption of HIFU as a focal therapy modality, targeting clinically significant ...
Sunao Shoji, Satoshi Kuroda, Airi Ichige, Naoko Matsumoto, Kumpei Takahashi, Tatsuya Otaki, Nobuyuki Nakajima, Yoshiaki Kawamura   +7 more
wiley   +1 more source

Diagnostic Value of Rapid On-Site Evaluation Combined With Prostate Biopsy in Prostate Cancer. [PDF]

Prostate
Ma H, Cao A, Hou H, Wu P, Wan B, Liu M.
europepmc   +1 more source

Prostatic biopsy. [PDF]

BMJ, 1980
openaire   +2 more sources

Prostatic stromal tumors with uncertain malignant potential: A scoping review of clinical challenges and management strategies

UroPrecision, EarlyView.
Abstract Prostatic stromal tumor of uncertain malignant potential (STUMP) is a rare neoplasm arising from specialized prostatic stromal cells with a broad range of histologic patterns and unpredictable clinical behavior. It is often challenging to distinguish STUMP from prostatic stromal sarcoma due to morphological similarities, necessitating specific
Ibrahim A. Khalil, Abdullah M. Al‐Jubouri, Khaled Murshed, Ahmad R. Al‐Qudimat, Majd Alkabbani, Nagy Younes, Khalid Al Jalham, Khalid Al Rumaihi   +7 more
wiley   +1 more source